| 21-May-13 05:46PM | Pfizer Stock Checkup for May at Motley Fool |
| 05:30PM | Positive Data on Novartis' Afinitor Zacks |
| 01:44PM | Flush With Cash, Elan Goes on a Buying Spree at Motley Fool |
| 09:10AM | Will Influenza A H7N9 Generate Opportunities For Pharma? at Seeking Alpha |
| 02:06AM | Johnson & Johnson Stock Checkup for May at Motley Fool |
| 20-May-13 06:07PM | Actavis, Warner Chilcott Stocks Rise On Merger News at Investor's Business Daily |
| 02:27PM | Ireland Welcomes Watson Pharmaceuticals, an American Success at TheStreet |
| 01:50PM | [$$] Actavis Prepares for Its Next Act at Barrons.com |
| 11:18AM | Actavis, Warner Chilcott Stocks Rise On Merger News at Investor's Business Daily |
| 08:01AM | Actavis buying Warner Chilcott in $8.5B deal AP |
| 08:00AM | Early Movers: YHOO, CPB, BA, GE & More at CNBC |
| 07:23AM | Actavis to Buy Warner Chilcott in $5B Stock Deal at Fox Business |
| 19-May-13 02:00PM | Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started at Motley Fool |
| 08:23AM | The 5 Richest Countries in the World at Motley Fool |
| 17-May-13 05:01PM | Novartis AG (NVS): Today's Featured Drugs Laggard at TheStreet |
| 16-May-13 02:05PM | 3 Companies That Put the "Tech" in "Biotech" at Motley Fool |
| 08:11AM | Novartis says no intention of pursuing Actavis, Bloomberg reports theflyonthewall.com |
| 07:33AM | Early Movers: WMT, KSS, CSCO & More at CNBC |
| 07:33AM | Morning Briefing: 10 Things You Should Know at TheStreet |
| 15-May-13 06:40PM | Angelina Jolie's Selfless Act Heightens Breast Cancer Awareness at Motley Fool |
| 05:16PM | Good News for Novartis' Ilaris Zacks |
| 04:59PM | Why Bristol-Myers Is Soaring at Motley Fool |
| 01:06PM | A Wall Street Transcript Interview with Russell Sims, Portfolio Manager and Director of Research for Osborn Rohs Williams & Donohoe: Three Equity Strategies for Investing in Quality Companies Wall Street Transcript |
| 11:07AM | Europe Shares Close Higher as Risk-On Rally Resumes at CNBC |
| 10:59AM | Novartis Reaches New 52-Week High (NVS) at TheStreet |
| 09:24AM | Aveo Screwed Up but Its Kidney Cancer Drug Is Real at TheStreet |
| 05:53AM | The Hidden Opportunity of the Novel Coronavirus at Motley Fool |
| 05:45AM | Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock at Seeking Alpha |
| 13-May-13 03:55PM | Big Pharma's Biggest Winners at Motley Fool |
| 03:17PM | Hospital to probe East German medical trials AP |
| 08:50AM | Earnings Beat for PETS, Margins Up Zacks |
| 06:17AM | Is Johnson & Johnson Heading Off The Patent Cliff? at Seeking Alpha |
| 12-May-13 06:21PM | Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company? at Seeking Alpha |
| 11-May-13 03:42PM | 6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II at Motley Fool |
| 11:10AM | Should You Own Pfizer Stock? at Wall St. Cheat Sheet |
| 10-May-13 05:09PM | Suspicions Raised About Another Japanese Cardiovascular Researcher at Forbes |
| 11:59AM | Europe Closes Higher, Boosted by Novartis, BT at CNBC |
| 10:06AM | Europe Closes Off Highs After Italy Data at CNBC |
| 09:02AM | Should We Get Bullish on This Fast Growing Healthcare Company? at Motley Fool |
| 09-May-13 05:01PM | Novartis AG (NVS): Today's Featured Drugs Laggard at TheStreet |
| 12:18PM | Will $15 Billion Work for This Troubled Drug Maker? at Motley Fool |
| 10:02AM | Companies Fighting Against Prostate Cancer at Seeking Alpha |
| 09:58AM | Law Enforcement In The Health Care Industry: What Do New Cases Against Novartis Tell Us? at Forbes |
| 08:35AM | Narrower than Expected Loss at Infinity Zacks |
| 07:30AM | Big Drug Companies Are Selling Fewer Pills, But Charging More at Forbes |
| 03:36AM | Did This Stock Deserve This Sudden Upward Swing? at Motley Fool |
| 08-May-13 01:03PM | Today's Stocks Driving Success For The Health Care Sector at TheStreet |
| 09:58AM | Novartis Reaches New 52-Week High (NVS) at TheStreet |
| 09:43AM | Why Psychiatry's Seismic Shift Will Happen Slowly at Forbes |
| 02:02AM | Teva's CEO Thinks China Is A 'Natural Fit' at Seeking Alpha |
| 07-May-13 06:54PM | Does Ariad's Leukemia Drug Have Hidden Potential? at Motley Fool |
| 04:42PM | 3 Bio Companies Facing The Patent Cliff at Seeking Alpha |
| 02:21PM | Is the Biggest Pharma Company in the World the Best Investment? at Motley Fool |
| 09:20AM | QLT Narrows Loss Zacks |
| 08:12AM | Small Companies Are Leading Innovation For New Drugs To Treat Depression at Forbes |
| 06-May-13 04:20PM | Investors Clamor for Generic Drug ETF ETF Trends |
| 03:32PM | Ophthalmology: A Niche Where Innovation Pays at Seeking Alpha |
| 08:40AM | Even Pharma's Good Deeds Are Criticized at Forbes |
| 05-May-13 02:30PM | Take a Deep Breath Before This Big FDA Decision at Motley Fool |
| 03-May-13 10:18PM | Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential at Seeking Alpha |
| 05:25PM | Regeneron Earnings Soar As Eylea Sales Skyrocket Investor's Business Daily |
| 02:10PM | Teva Still Too Cheap, But Still Too Uncertain at Investopedia |
| 01:40PM | Narrower-Than-Expected Loss at Incyte Zacks |
| 11:47AM | Faster Drug Approval Process Results as Consequence of Closer Collaboration Between Drug Manufacturers and the FDA: Learn Which Antibiotic Companies Are Benefiting in this Exclusive Interview Wall Street Transcript |
| 02-May-13 03:58PM | I Would Buy a Generic Drug ETF, If One Existed at Motley Fool |
| 03:51PM | Stagflationary, Muddling, Sideways Economy And Market at Seeking Alpha |
| 08:28AM | 3 Pharma Stocks to Buy for the Long Run at Motley Fool |
| 01-May-13 08:46PM | Why America Is Suing This Pharmaceutical Behemoth at Motley Fool |
| 08:30PM | Why Allergan's Pain Is Regeneron's Gain at Motley Fool |
| 06:09PM | Big Pharma's Kickback Conundrum at Motley Fool |
| 02:07PM | Swinging For The Fences With Advanced Cell Technology at Seeking Alpha |
| 30-Apr-13 06:37PM | Pfizer 1Q profit up, but drugmaker cuts outlook AP |
| 05:25PM | Pfizer 1Q profit up, but drugmaker cuts outlook AP |
| 04:34PM | Pfizer 1Q profit up, but drugmaker cuts outlook AP |
| 03:58PM | Pfizer 1Q profit up, but drugmaker cuts outlook AP |
| 03:07PM | Pfizer Q1 profit up, but drugmaker cuts outlook AP |
| 11:36AM | Focusing on Biotech Companies with Opportunities from a Valuation Perspective: An Expert Analyst Discusses the Hidden Value in the Biotech and Pharmaceutical Sectors Wall Street Transcript |
| 09:52AM | 3 Misunderstood Large Cap Value Finds at Motley Fool |
| 29-Apr-13 01:11PM | [video] Novartis Disputes Allegations at CNBC |
| 12:53PM | A Tale Of Three Pharmaceuticals: Getting Exciting In 2013 at Seeking Alpha |
| 11:50AM | Novartis Rebuts Government Allegations of Misconduct at Motley Fool |
| 11:50AM | Biogen Stock Hits High On Strong Tecfidera Report at Investor's Business Daily |
| 09:05AM | ImmunoGen Narrows Loss Zacks |
| 28-Apr-13 09:26PM | Has Novartis Been Bribing Your Doctor? at Wall St. Cheat Sheet |
| 27-Apr-13 04:01AM | [$$] Review at Barrons.com |
| 26-Apr-13 09:33PM | U.S. Sues Novartis Again, Accusing It of Kickbacks at New York Times |
| 09:33PM | U.S. Sues Novartis Again, Accusing It of Kickbacks at New York Times |
| 06:52PM | Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts PR Newswire |
| 03:57PM | U.S. Files Suit Accusing Novartis of Paying Kickbacks to Doctors at Fox Business |
| 03:15PM | [$$] U.S. Says Novartis Paid Doctors Kickbacks at The Wall Street Journal |
| 03:09PM | [$$] U.S. Says Novartis Paid Doctors Kickbacks at The Wall Street Journal |
| 11:50AM | Wall Street Transcript Interview with Dr. Bassam Damaj, President and CEO of Innovus Pharmaceuticals, Inc. (INNV) Wall Street Transcript |
| 08:07AM | Zacks Bull and Bear of the Day Highlights: Overstock.com, Titan Machinery, Acorda Therapeutics, Biogen Idec and Novartis Zacks |
| 25-Apr-13 11:50PM | Doctors blast ethics of $100,000 cancer drugs at CNNMoney.com |
| 05:27PM | Cancer Doctors Raise Pressure On Pharma Industry To Cut Drug Prices at Forbes |
| 05:01PM | Hospira shares climb 4%; rumors of patent settlement driving price? at MarketWatch |
| 05:00PM | Acorda Initiates Study on rHIgM22 Zacks |
| 04:30PM | FDA Designation for Merck Candidate Zacks |
| 12:51PM | Questcor Pharmaceuticals: How Can Such A Profitable Company Be So Risky? at Seeking Alpha |
| 11:10AM | Novartis' Earnings, Sales Beat Estimates Zacks |
